Novartis: Retinal Vein Occlusion trials
The registry lists 20 Retinal Vein Occlusion studies with Novartis as lead sponsor. 0 are open to participants now and 14 have results posted.
Phase 1 2Phase 2 1Phase 3 11Phase 4 4No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)CompletedNCT05269966Phase 4Results posted
- Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular DegenerationCompletedNCT04264819Phase 3Results posted
- Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular EdemaCompletedNCT03927690Phase 2Results posted
- Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein OcclusionTerminatedNCT03810313Phase 3Results posted
- Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein OcclusionTerminatedNCT03802630Phase 3Results posted
- Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and SafetyCompletedNCT02953938Phase 4Results posted
- Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.CompletedNCT02140411Phase 4Results posted
- Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01976338Phase 3Results posted
- Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)CompletedNCT01976312Phase 3Results posted
- Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein OcclusionCompletedNCT01599650Phase 3Results posted
- Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVOCompletedNCT01580020Phase 4Results posted
- Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein OcclusionCompletedNCT01535261Phase 3Results posted
- Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)CompletedNCT01396083Phase 3Results posted
- Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01396057Phase 3Results posted
- Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved IndicationsCompletedNCT04847895
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema PatientsCompletedNCT04635800Phase 1
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular EdemaCompletedNCT02867735Phase 1
- Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein OcclusionCompletedNCT01377597Phase 3
- Observe the Effectiveness and Safety of Ranibizumab in Real Life SettingCompletedNCT01318941
- Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)CompletedNCT00942864Phase 3